Dishman Pharmaceuticals & Chemicals Ltd.: corporate announcements

231 records, the earliest from 1 Nov 2010. As filed with the exchanges; the history is only as deep as the data Tradinity has collected.

Bulk & block deals Corporate actions Announcements Dividends Board meetings Insider trading & SAST Download CSV

231 shown.

Date	Category	Subject
22 May 2017 13:49	Suspension of Trading	DISHMAN: Members of the Exchange are hereby informed that the trading in Equity Shares of Dishman Pharmaceuticals and Chemicals Limited shall be suspended w.e.f. May 30, 2017 (i.e. closing hours of trading on May 29, 2017) on account of Scheme of Amalgamation of Dishman Pharmaceuticals and Chemicals Limited with Carbogen Amcis (India) Limited.
19 May 2017 11:49	Record Date	Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that the Board of directors of Amalgamated entity i.e Dishman Carbogen Amcis Limited, in its meeting held on May 19, 2017 has fixed Record Date as May 31, 2017 for the purpose of deciding the members who shall be eligible for allotment of equity shares of the amalgamated entity, Dishman Carbogen Amcis Limited to the shareholders of erstwhile Dishman Pharmaceuticals and Chemicals Limited ("DPCL") in the ratio of 1:1 i.e. Share Exchange Ratio [1 (One) fully paid-up Equity Share of Rs.2/- (Rupees Two only) each of DCAL, for every 1 (One) fully paid-up Equity Share of Rs.2/ (Rupees Two only) each held by such shareholder in DPCL], fixed under the Scheme of Arrangement and Amalgamation approved by the Hon'ble High Court of Gujarat.
17 May 2017 10:47	Investor Presentation	Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding Investor Presentation
16 May 2017 16:18	Financial Result Updates	Dishman Pharmaceuticals and Chemicals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2017.
15 May 2017 07:13	Analysts/Institutional Investor Meet/Con. Call Updates	Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
8 May 2017 11:22	Trading Window	Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
18 Apr 2017 09:11	Credit Rating	Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding Credit Rating
10 Apr 2017 13:44	Disc. under Reg.30 of SEBI (SAST) Reg.2011	Bhadra Raj Holdings Private Limited has submitted to the Exchange vide letter dated April 06, 2017 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
6 Apr 2017 10:56	Disclosure under SEBI Takeover Regulations	Bhadra Raj Holdings Pvt Ltd has submitted to the Exchange, vide letter dated April 5, 2017 a copy of disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
28 Mar 2017 08:06	News Verification	The Exchange has sought clarification from Dishman Pharmaceuticals and Chemicals Limited with respect to recent news item captioned "US FDA Approves Zejula Capsules.". The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Dishman Pharmaceuticals and Chemicals Limited has submitted their response.

Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.